Safety Evaluation of Tradipitant Dosing in 4-Organ Human-on-a-Chip System to be Presented at SOT 2026
A 4-organHuman-on-a-Chip® model was used to study the safety profile of tradipitant, the results supported its recent approval for motion sickness.
Presentation Details
Safety Evaluation of Supraphysiological Tradipitant Dosing under Differential Liver Metabolism
Presented by: Jessie Carlin, Ph.D., Vanda Pharmaceuticals
Monday, March 23, 2026, 4:15 PM PDT
Ballroom 6C
Learn more and discover how we can advance your pipeline faster and more efficiently
Explore Other Hesperos News
Hesperos at Microphysiological Systems World Summit 2026
Join Hesperos at the 2026 MPS World Summit in Washington, DC If you are attending the MPS World Summit (Washington, DC, 26 – 29 May 2026), please stop by Booth 523 to learn more about how … Read More
Hesperos and UCF Researchers Publish Human-on-a-Chip® Study Revealing Peripheral Neuromuscular Pathology is not CNS Dependent in Alzheimer’s Disease
Hesperos and UCF publish new study in Alzheimer’s and Dementia demonstrating peripheral neuromuscular pathology is NOT CNS dependent in Alzheimer’s Disease
